DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation
Author:
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/s41388-020-1386-1.pdf
Reference46 articles.
1. Lu X, Liu R, Wang M, Kumar AK, Pan F, He L, et al. MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer. Oncogene. 2020;39:234–47.
2. Zhou T, Pan FY, Cao Y, Han Y, Zhao J, Sun HF, et al. R152C DNA Pol beta mutation impairs base excision repair and induces cellular transformation. Oncotarget. 2016;7:6902–15.
3. Wang M, Li E, Lin L, Kumar AK, Pan F, He L, et al. Enhanced activity of variant DNA polymerase beta (D160G) contributes to cisplatin therapy by impeding the efficiency of NER. Mol Cancer Res. 2019;17:2077–88.
4. Broustas CG, Lieberman HB. DNA damage response genes and the development of cancer metastasis. Radiat Res. 2014;181:111–30.
5. Rytelewski M, Tong JG, Buensuceso A, Leong HS, Maleki Vareki S, Figueredo R, et al. BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis. Mol Oncol. 2014;8:1429–40.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Implication of IZUMO2 in the cell‐in‐cell phenomenon: A potential therapeutic target for triple‐negative breast cancer;Thoracic Cancer;2024-01-23
2. DNA polymerase beta connects tumorigenicity with the circadian clock in liver cancer through the epigenetic demethylation of Per1;Cell Death & Disease;2024-01-20
3. Correction: DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation;Oncogene;2023-11-27
4. DNA polymerase beta connects tumorigenicity with the circadian clock in liver cancer through the epigenetic demethylation of Per1;2023-10-06
5. ER stress decreases exosome production through adiponectin/T-cadherin-dependent and -independent pathways;Journal of Biological Chemistry;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3